FDA approves daily pill to treat low libido in women after menopause: What to know
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin)Trusted Source for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.
Read More
HealthTimes Unveils Interactive New Website Ahead of Its 9th Year
By Staff Reporter As HealthTimes enters its ninth year in 2026, the digital news platform has marked a significant milestone with the launch of its new-look website, designed to meet the evolving demands of readers and align with global digital trends. “We ran on the old theme for 8 years, and the old boy now
Read More
A Silent Spillover: Backyard Livestock Antibiotic Use and Africa’s Rising AMR Threat
By Michael Gwarisa Smallholder livestock farming remains a cornerstone of livelihoods, food security, and rural economies across sub-Saharan Africa. Millions of households rely on animals such as chickens, goats, sheep, and cattle not only for daily nutrition but also as a critical source of income. In recent years, the sector has expanded rapidly, driven by
Read More